This one-day course provides an overview of the causes, mechanisms and management of multiple sclerosis from both a clinical management and a drug development perspective.
This course is suitable for pharmaceutical, biotech and other healthcare personnel involved in product management, strategic marketing, research and development, sales, training, medical affairs and pharmacovigilance of drugs used in Multiple Sclerosis.
This clinical experience programme will provide participants with an overview of the spectrum of malignant disease. The manifestation, presentation, investigation and management of a range of common solid tumour types (breast, lung, colorectal, gynaecological, gastrointestinal, prostate) will be reviewed. Clinicians active in these areas will examine patient management throughout the process. The context of cancer care will also be reviewed including the epidemiology of cancer and factors affecting treatment choices and prescribers' decision-making.
This course is suitable for pharmaceutical industry personnel from clinical research, medical affairs, regulatory and strategic marketing functions working in drug development and marketing of oncology products and compounds.
(0.3 ceu) This course orients you to the Post-Baccalaureate Health Professions Program and assists you in planning your course of study. You learn skills that support your success in the program and clarify your understanding of and interest in specific health care careers. Prerequisites: You must be officially accepted into the Post-Baccalaureate Health Professions Program.
The third-annual premier conference in the ubiquitin field. This year's event will host an exciting cast of ubiquitin-focused distinguished faculty from the academic, pharmaceutical, biotech and business communities. The third-annual premier conference in the ubiquitin field. This year's event will host an exciting cast of ubiquitin-focused distinguished faculty from the academic, pharmaceutical, biotech and business communities. The program will focus on advances and opportunities in oncology, infectious diseases, neurodegeneration, inflammation, diabetes, and muscle wasting.
Learn to understand, define, apply, and execute project management best practices in drug discovery and preclinical development. Master the framework for developing a preclinical plan based on a solid target product profile, and explore ways to gain efficiencies in terms of time budgets and resource usage. This course covers the critical elements of the drug development discovery phase before detailing how project management can make the preclinical phase of drug development more efficient.
Get an introduction to the regulatory authorities, whose regulations and requirements must be implemented and met to ensure compliance to the laws governing this industry. Learn the steps leading to testing products in humans, the approval of products and post-approval requirements, and industry implementation.
Gain an understanding of the biotechnology industry-what makes it so compelling and what makes it one of the riskiest sectors for investors. Study the career paths of some of the innovative entrepreneurs who created the industry back in the late 1970s. Learn about the risks they took and how the value they generated surpassed even that of dot-com successes. You also get a guided tour of the mysteries of the drug development process and the convoluted funding trail, from venture capital through that all-important initial public offering (IPO).
WORLDx Congress will offer the most up-to-date insight into new FDA strategies and highlight strategies for success in biomarker validation, partnerships formation, regulatory compliance and reimbursement.
This course will provide a comprehensive overview of how nanomaterials such as nanoparticles, nanocapsules, micelles, microemulsions, liposomes, nanoporous materials, and polymer multilayers can be prepared, stabilized, surface-functionalized and assembled for applications in biotechnology, biomedicine, and pharmaceuticals. Specific applications include biosensing, drug delivery, imaging, bioseparations, biocatalysis, biomolecular assembly, and molecular diagnostics.
The goal of this course is to present a comprehensive overview of how soft and hard nanomaterials can be prepared, modified and used in a variety of biotechnology, biomedicine and pharmaceutical applications, to industrial scientists and engineers and those with managerial responsibility for research. First the course will cover the fundamental physical chemical principles that govern the formation and properties of soft nanomaterials such as micelles, vesicles, microemulsions, liposomes, block copolymer nanocolloids, polymer multilayers and nanocapsules. The preparation of nanoparticles and nanoporous materials will be also be described. Second, methods to stabilize and functionalize nanomaterials, important experimental techniques to characterize the properties of structured fluids and nanoparticles, and methods to assemble nanoparticles in one, two or three dimensions for applications will be reviewed. Third, the applications of soft and hard nanomaterials to various areas of bio and pharmaceutical technologies will be discussed. Specifically, applications including biosensing, drug delivery, imaging, bioseparations, biocatalysis, biomolecular assembly, and molecular diagnostics will be emphasized. Throughout the course, effort will be made to provide a molecular and intuitive understanding of the field, accompanied wherever necessary by quantitative models.
WHO SHOULD ATTEND
This course is designed for industrial scientists and engineers and research managers. The following groups will find the course of value to them:
biologists, physicists, chemists and engineers interested in gaining exposure to the field of structured fluids and nanoparticles, including their physical chemical foundations and experimental characterization methods for adapting them in their own research activities; engineers and scientists in the pharmaceutical, food, cosmetics, personal care products, and biotechnology industries, who are interested to learn how the soft and hard nanomaterials can be exploited to create new products or processes of relevance to their industries; managers responsible for research and development activities or process engineering who would like to gain an appreciation of the potential benefits that can emerge from the use of structured fluids and nanoparticles for creating new products or processes.
The ways in which chemicals or drugs are administered have gained increasing attention in the past two decades. Normally, a chemical is administered in a high dose at a given time only to have to repeat that dose several hours or days later. This is not economical and sometimes results in damaging side effects. As a consequence, increasing attention has been focused on methods of giving drugs continually for prolonged time periods and in a controlled fashion. The primary method of accomplishing this controlled release has been through incorporating the chemicals within polymers. This technology now spans many fields and includes pharmaceutical, food and agricultural applications, pesticides, cosmetics, and household products.
In the pharmaceutical field, in addition to the importance of polymers, an understanding of the physiological barriers in the human body is also critical to developing appropriate controlled release systems. The skin, the gastrointestinal tract, the nose and the eye are of particular importance. Finally, recent advances in genetic engineering have spawned numerous new polypeptide agents and DNA and siRNA. Approaches for delivering and stabilizing these molecules will be discussed.
The lectures, in morning and afternoon sessions, will be presented by faculty members at MIT and other universities who are leaders in the topics to be covered. The lectures are intended to review the recent advances in the art and science of controlled release technology and to assess the prospects and directions of future developments. The program is designed for chemists, chemical engineers, pharmaceutical scientists, and technical managers with an interest in controlled release technology. Scientists in other fields such as food, agricultural, etc., may also benefit from this course.
TEACHING FACULTY Dr. Robert Langer, Program Director
Dr. Alexander Klibanov, Professor of Chemistry at MIT.
Dr. Frank W. Harris, Professor of Polymer Science at the University of Akron's Polymer Institute.
Dr. Nicholas A. Peppas, Fletcher S. Pratt Chair of Chemical Engineering, Biomedical Engineering and Pharmaceutics at the University of Texas at Austin.
Dr. Frank Szoka, Professor for the College of Pharmacy at the University of California, San Francisco.
